Risk of suicidal ideation lower in semaglutide than non-GLP-1 medication

American researchers have suggested that the risk of suicidal ideation in adults using obesity and diabetes medication semaglutide is lower than those prescribed non-GLP-1 medication. The study, which is published in Nature Medicine, concludes that further research is needed to understand the perceived link.

Healio